Rebuttal from Drs Suissa and Rabe
- PMID: 24798832
- DOI: 10.1378/chest.14-0113
Rebuttal from Drs Suissa and Rabe
Comment on
-
Counterpoint: were industry-sponsored roflumilast trials appropriate? No.Chest. 2014 May;145(5):939-42. doi: 10.1378/chest.14-0114. Chest. 2014. PMID: 24798831 Free PMC article. No abstract available.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical